News tagged with chronic liver
Research finds kava is safe and effective
(PhysOrg.com) -- UQ research has found a traditional extract of kava, a medicinal plant from the South Pacific, to be safe and effective in reducing anxiety.
Medicine & Health / Psychology & Psychiatry
May 11, 2009 |
4.5 / 5 (12) |
1
New study upends thinking about how liver disease develops
In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic ...
Medicine & Health / Medical research
Dec 20, 2010 |
4.6 / 5 (5) |
0
|
Chinese vaccine shields against hepatitis E - Lancet
A prototype vaccine devised and tested in China has proven 100-percent effective in preventing hepatitis E, a disease that is widespread in the developing world and can be fatal, investigators reported in The Lancet on Mon ...
Medicine & Health / Medications
Aug 23, 2010 |
5 / 5 (4) |
1
Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers
Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study led by Neal ...
Medicine & Health / Diseases, Conditions, Syndromes
Oct 20, 2009 |
5 / 5 (3) |
0
New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report published Monday in the ...
Medicine & Health / Diseases, Conditions, Syndromes
Aug 08, 2010 |
5 / 5 (3) |
0
Purple periwinkles battle inflammatory diseases
A widely and safely used plant extract acts as a novel anti-inflammatory agent that may one day be used for the treatment of chronic obstructive pulmonary disease, or COPD, as well as other inflammatory conditions. There ...
Medicine & Health / Medical research
May 03, 2010 |
5 / 5 (2) |
1
Game changer: Hepatitis C drug may revolutionize treatment
The drug boceprevir helps cure hard-to-treat hepatitis C, says Saint Louis University investigator Bruce R. Bacon, M.D., author of the March 31 New England Journal of Medicine article detailing the study's findings. The re ...
Medicine & Health / Diseases, Conditions, Syndromes
Mar 30, 2011 |
3 / 5 (2) |
0
Toward explaining why hepatitis B hits men harder than women
Scientists in China are reporting discovery of unusual liver proteins, found only in males, that may help explain the long-standing mystery of why the hepatitis B virus (HBV) sexually discriminates -- hitting ...
Nov 18, 2009 |
5 / 5 (1) |
0
NIH study offers hope to patients with nonalcoholic steatohepatitis
A daily dose of a specific form of vitamin E significantly improved the liver disease, nonalcoholic steatohepatitis (NASH), according to a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 28, 2010 |
5 / 5 (1) |
0
Fatal assaults 30 times higher among poor Scots than among most affluent
Fatal assaults among the most disadvantaged in Scotland are more than 30 times as high as they are among the most affluent sectors of society, reveals research published today in the Journal of Epidemiology and Community He ...
May 05, 2010 |
5 / 5 (1) |
1
US panel gives nod to Merck hepatitis C drug
A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.
Medicine & Health / Medications
Apr 27, 2011 |
5 / 5 (1) |
0
New Target Identified for Scleroderma Therapy
(PhysOrg.com) -- Investigators at Northwestern University Feinberg School of Medicine have identified the molecule Egr-1 (early growth response factor 1) as a new therapy target for scleroderma, an autoimmune disease for ...
Medicine & Health / Diseases, Conditions, Syndromes
Jun 14, 2010 |
4 / 5 (1) |
0
Death certificates confirm non-HIV-attributable diseases cause increase in US PLWHA deaths
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of ...
Medicine & Health / HIV & AIDS
Dec 01, 2010 |
4 / 5 (1) |
0
Donor kidneys from Hepatitis C patients needlessly denied to patients with that infection
More than half of donor kidneys in the United State infected with hepatitis C are thrown away, despite the need among hepatitis C patients who may die waiting for an infection-free organ, Johns Hopkins research suggests.
Medicine & Health / Diseases, Conditions, Syndromes
Apr 01, 2010 |
3 / 5 (1) |
0
Study shows liver transplant center impacts patient outcomes
For patients in need of a liver transplant, their choice of a transplant center can make a noteworthy difference in their outcomes, according to a Mayo Clinic study presented at the American Transplant Congress under way ...
May 03, 2010 |
3 / 5 (1) |
0
